Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer

Abstract

PurposeTo investigate the association of cancer stem-cell markers [octamer-binding transcription factor 4 (OCT4), sex determining region Y-box 2 (SOX2), and Nanog homebox (NANOG)] expression with clinicopathological properties and overall survival (OS) in operative rectal cancer (RC) patients receiving adjuvant therapy.Materials and Methods153 patients with primary RC receiving surgery were enrolled. Tumor tissue and paired adjacent normal tissue sample were collected, and OCT4, SOX2, and NANOG expressions were assessed by immunofluorescent staining. The median follow-up duration was 5.2 years, and the last follow-up date was August 2016.ResultsTumor tissue OCT4 (p<0.001), SOX2 (p=0.003), and NANOG (p<0.001) expressions were higher than those in adjacent tissue. OCT4 expression was positively correlated with pathological grade (R=0.185, p=0.022), tumor size (R=0.224, p=0.005), and N stage (R=0.170, p=0.036). NANOG expression was positively associated with tumor size (R=0.169, p=0.036). Kaplan-Meier suggested that OCT4+ was associated with worse OS compared with OCT4− (p<0.001), while no association of SOX2 (p=0.121) and NANOG expressions (p=0.195) with OS was uncovered. Compared with one or no positive marker, at least two positive markers were associated with shorter OS (p<0.001), while all three positive markers were correlated with worse OS compared with two or less positive markers (p<0.001). Multivariate Cox's analysis revealed that OCT4+ (p<0.001) and N stage (p=0.046) were independent factors for shorter OS.ConclusionTumor tissue OCT4 expression was correlated with poor differentiation, tumor size, and N stage, and it can serve as an independent prognostic biomarker in operative patients with RC receiving adjuvant therapy.

miR‐365 regulates liver cancer stem cells via RAC1 pathway

“…It was reported that the stem cell associated genes, including OCT4, SOX-2 and Nanog and so on, have important roles in liver CSCs regulation. [25][26][27] As expected, miR-365 overexpression downregulated the expression of stemness-associated genes ( Figures 3A and 3B) and liver CSC markers in hepatoma cells ( Figures 3C and 3D), which further supported that miR-365 could inhibit liver CSCs expansion.…”

Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma

“…POU5F1 has been studied for a long period of time as a well-known CSCs marker, which participates in tumor invasion, differentiation and recurrence [67]. A growing number of researches have suggested the prognostic value of POU5F1 in various malignancies.…”

Modern Radiotherapy Regimens and Biomarkers of Radioresistant Rectal Tumor Cells

“…Исследования в области биомаркеров радиорезистентности опухолевых клеток вызывают большой научный интерес [20][21][22][23][24]. Все биомаркеры ответа опухоли на лучевую терапию можно разделить на три группы:…”